Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bionicjoeon Apr 25, 2019 10:07am

74 Views

Post# 29668948

RE:RE:RE:RE:RE:LaserStock29

tomchoco wrote: No offense Bionic but you are way too negative for me and I am always negative on stocks. Not sure who you are working for but you are bad karma for my position here. Added to the ignore button.

No hard feelings but I just want to hear positive on Theralase.

Interesting, you invest in stocks only by trusting in the hype as presented on a SH board. It seems you missed where in the NR the company didn't offer a timeline when they expect patients to begin treatment or which sites will treat patients in Canada. That will take time so it's a fair assessment to say the Canadian arm of the trial would need a few months before running at top speed if such a thing can even be applied to a clinical trial.

Bullboard Posts

Stockhouse DealRoom opens new Australian opportunities